Literature DB >> 26792788

Obesity with abundant subcutaneous adipose tissue increases the risk of post-ERCP pancreatitis.

Toshio Fujisawa1, Koichi Kagawa2, Kantaro Hisatomi2, Kensuke Kubota3, Hajime Sato4, Atsushi Nakajima3, Nobuyuki Matsuhashi2.   

Abstract

BACKGROUND/
PURPOSE: The risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) have been widely investigated. However, studies focusing on the body mass index (BMI) and distribution of adipose tissue have not been reported. Therefore, we examined the correlation between PEP and these factors.
METHODS: A total of 583 consecutive endoscopic retrograde cholangiopancreatography (ERCP)-naïve patients undergoing therapeutic ERCP were retrospectively analyzed. Subjects were categorized into four groups by BMI: underweight, normal, overweight, and obesity; the PEP rates were compared. In addition, the relationship between PEP and parameters of obesity, visceral and subcutaneous adipose tissue as well as abdominal circumference was investigated.
RESULTS: PEP rate was significantly higher in obesity (30 %) and lower in normal (3 %, P < 0.001). The PEP rate in underweight (7.3 %) was conversely higher than in normal. As for parameters of obesity, only subcutaneous adipose tissue was correlated with PEP incidence (P = 0.009). The correlation of PEP incidence with BMI and subcutaneous adipose tissue was separately reconfirmed by multivariate analysis including female gender and guidewire placement; these factors showed a tendency toward differences in univariate analysis.
CONCLUSIONS: Obesity could be a risk factor for PEP. In the obesity group, an excess of subcutaneous adipose tissue might be an especially important factor related to PEP incidence.

Entities:  

Keywords:  Body mass index; Obesity; Post-ERCP pancreatitis; Subcutaneous adipose tissue; Visceral adipose tissue

Mesh:

Year:  2016        PMID: 26792788     DOI: 10.1007/s00535-016-1160-x

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  32 in total

1.  A lexicon for endoscopic adverse events: report of an ASGE workshop.

Authors:  Peter B Cotton; Glenn M Eisen; Lars Aabakken; Todd H Baron; Matt M Hutter; Brian C Jacobson; Klaus Mergener; Albert Nemcek; Bret T Petersen; John L Petrini; Irving M Pike; Linda Rabeneck; Joseph Romagnuolo; John J Vargo
Journal:  Gastrointest Endosc       Date:  2010-03       Impact factor: 9.427

2.  A large volume of visceral adipose tissue leads to severe acute pancreatitis.

Authors:  Yoko Yashima; Hiroyuki Isayama; Takeshi Tsujino; Rie Nagano; Keisuke Yamamoto; Suguru Mizuno; Hiroshi Yagioka; Kazumichi Kawakubo; Takashi Sasaki; Hirofumi Kogure; Yousuke Nakai; Kenji Hirano; Naoki Sasahira; Minoru Tada; Takao Kawabe; Kazuhiko Koike; Masao Omata
Journal:  J Gastroenterol       Date:  2011-07-30       Impact factor: 7.527

Review 3.  Obesity-related insulin resistance: implications for the surgical patient.

Authors:  N Tewari; S Awad; I A Macdonald; D N Lobo
Journal:  Int J Obes (Lond)       Date:  2015-06-01       Impact factor: 5.095

4.  Genetically determined prospect to become long-lived is associated with less abdominal fat and in particular less abdominal visceral fat in men.

Authors:  Michiel L Sala; Boudewijn Röell; Noortje van der Bijl; Jeroen van der Grond; Anton J M de Craen; Eline P Slagboom; Rob van der Geest; Albert de Roos; Lucia J M Kroft
Journal:  Age Ageing       Date:  2015-05-16       Impact factor: 10.668

5.  Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.

Authors:  K Hotta; T Funahashi; N L Bodkin; H K Ortmeyer; Y Arita; B C Hansen; Y Matsuzawa
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

6.  Complications of ERCP: a prospective study.

Authors:  Merete Christensen; Peter Matzen; Svend Schulze; Jacob Rosenberg
Journal:  Gastrointest Endosc       Date:  2004-11       Impact factor: 9.427

7.  Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.

Authors:  E Masci; A Mariani; S Curioni; P A Testoni
Journal:  Endoscopy       Date:  2003-10       Impact factor: 10.093

8.  Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years.

Authors:  Peter B Cotton; Donald A Garrow; Joseph Gallagher; Joseph Romagnuolo
Journal:  Gastrointest Endosc       Date:  2009-03-14       Impact factor: 9.427

9.  Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study.

Authors:  Viju P Deenadayalu; Urszula Blaut; James L Watkins; Jeffrey Barnett; Martin Freeman; Joseph Geenen; Michael Ryan; Harrison Parker; James T Frakes; Evan L Fogel; William B Silverman; Kulwinder S Dua; Giuseppe Aliperti; Paul Yakshe; Michael Uzer; Whitney Jones; John Goff; M'hamed Temkit; Glen A Lehman; Stuart Sherman
Journal:  J Clin Gastroenterol       Date:  2008 Nov-Dec       Impact factor: 3.062

10.  Downregulation of ADIPOQ and PPARγ2 gene expression in subcutaneous adipose tissue of obese adolescents with hepatic steatosis.

Authors:  Romy Kursawe; Deepak Narayan; Anna M G Cali; Melissa Shaw; Bridget Pierpont; Gerald I Shulman; Sonia Caprio
Journal:  Obesity (Silver Spring)       Date:  2010-02-18       Impact factor: 5.002

View more
  5 in total

1.  The Burden of Systemic Adiposity on Pancreatic Disease: Acute Pancreatitis, Non-Alcoholic Fatty Pancreas Disease, and Pancreatic Cancer.

Authors:  Ahmad Malli; Feng Li; Darwin L Conwell; Zobeida Cruz-Monserrate; Hisham Hussan; Somashekar G Krishna
Journal:  JOP       Date:  2017

2.  Assessment of Computed Tomography-Defined Muscle and Adipose Tissue Features in Relation to Length of Hospital Stay and Recurrence of Hypertriglyceridemic Pancreatitis.

Authors:  Huajun Yu; Yingbao Huang; Lifang Chen; Liuzhi Shi; Yunjun Yang; Weizhi Xia
Journal:  Int J Gen Med       Date:  2021-05-05

3.  Impact of body mass index on the incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Mohamed M Abdelfatah; Nicholas J Koutlas; Eric Gochanour; Ahmed Hamed; Mariam Ibrahim; Mohamed Barakat; Prashant R Mudireddy
Journal:  Ann Gastroenterol       Date:  2019-03-12

4.  Morbid obesity but not obesity is associated with increased mortality in patients undergoing endoscopic retrograde cholangiopancreatography: A national cohort study.

Authors:  Bing Chen; Chia-Hung Yo; Ramya Patel; Bolun Liu; Ke-Ying Su; Wan-Ting Hsu; Chien-Chang Lee
Journal:  United European Gastroenterol J       Date:  2021-05-05       Impact factor: 4.623

5.  Does restricting fluid volume impact post-ERCP pancreatitis in patient with heart disease?

Authors:  Ko Tomishima; Shigeto Ishii; Toshio Fujisawa; Noboru Yatagai; Daishi Kabemura; Sho Sato; Nozomi Amano; Ayato Murata; Hironori Tsuzura; Shunsuke Sato; Kouhei Matsumoto; Yuji Shimada; Takuya Genda; Akihito Nagahara; Hiroyuki Isayama
Journal:  Saudi J Gastroenterol       Date:  2021 Nov-Dec       Impact factor: 2.485

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.